UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000060806 |
|---|---|
| Receipt number | R000068715 |
| Scientific Title | Evaluation of the usefulness of peroral pancreatoscopy in determining surgical indications for intraductal papillary mucinous neoplasms |
| Date of disclosure of the study information | 2026/03/03 |
| Last modified on | 2026/03/02 23:14:40 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Evaluation of the usefulness of peroral pancreatoscopy in determining surgical indications for intraductal papillary mucinous neoplasms
Acronym
Evaluation of the usefulness of peroral pancreatoscopy in determining surgical indications for intraductal papillary mucinous neoplasms
Scientific Title
Evaluation of the usefulness of peroral pancreatoscopy in determining surgical indications for intraductal papillary mucinous neoplasms
Scientific Title:Acronym
Evaluation of the usefulness of peroral pancreatoscopy in determining surgical indications for intraductal papillary mucinous neoplasms
Region
| Japan |
Condition
Condition
intraductal papillary mucinous neoplasms
Classification by specialty
| Hepato-biliary-pancreatic medicine |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The aim of this study is to clarify the impact of preoperative peroral pancreatoscopy (POPS) and POPS-guided biopsy on surgical decision-making in patients with intraductal papillary mucinous neoplasms.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Changes in surgical strategy based on peroral pancreatoscopy and POPS-guided biopsy in patients with intraductal papillary mucinous neoplasms
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | < |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients with intraductal papillary mucinous neoplasms who underwent peroral pancreatoscopy followed by surgical treatment.
Key exclusion criteria
1.Minors
2.Cases in which peroral pancreatoscopy could not reach the lesion due to technical reasons
3.Cases that included peroral pancreatoscopy data obtained at other institutions
4.Cases deemed inappropriate for analysis by the principal investigator or co-investigators because of missing clinical data or inadequate imaging
5.Cases in which the patient expressed refusal to participate in the study
Target sample size
60
Research contact person
Name of lead principal investigator
| 1st name | Ichiro |
| Middle name | |
| Last name | Yasuda |
Organization
University of Toyama
Division name
Third Department of Internal Medicine
Zip code
930-0194
Address
2630 Sugitani, Toyama city, Toyama prefecture, Japan
TEL
076-434-7301
yasudaich@gmail.com
Public contact
Name of contact person
| 1st name | Toshiki |
| Middle name | |
| Last name | Entani |
Organization
University of Toyama
Division name
Third Department of Internal Medicine
Zip code
930-0194
Address
2630 Sugitani, Toyama city, Toyama prefecture, Japan
TEL
076-434-7301
Homepage URL
tmpu_et@yahoo.co.jp
Sponsor or person
Institute
University of Toyama
Institute
Department
Personal name
Funding Source
Organization
none
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Center for Clinical Reserch in Toyama University Hospital
Address
2630 Sugitani, Toyama city, Toyama prefecture, Japan
Tel
076-415-8857
rinri@adm.u-toyama.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 03 | Month | 03 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
40
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2025 | Year | 09 | Month | 07 | Day |
Date of IRB
| 2025 | Year | 10 | Month | 23 | Day |
Anticipated trial start date
| 2025 | Year | 11 | Month | 01 | Day |
Last follow-up date
| 2030 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
none
Management information
Registered date
| 2026 | Year | 03 | Month | 02 | Day |
Last modified on
| 2026 | Year | 03 | Month | 02 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000068715
